British drugmaker GlaxoSmithKline (LSE: GSK) faces a higher wage bill after workers accepted an average 10.5% pay increase in return for calling off planned industrial action.
Members of Unite, a UK union, accepted the improved pay offer, after initially rejecting a planned 2.75% increase.
The ballot in April saw over 85% voting in favor of a strike, the first time GSK workers have done so in its history.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze